₹67 Crore Profit Masks a ₹150+ Crore Bet on Price Indexation
Revenue jumped 23.5% YoY and outpaced the automotive market, but margins compressed 140 bps due to cost headwinds totalling ₹150+ Crore. Management's recovery narrative hinges on customer price indexation in Q2-Q3—a credible path forward, but one that's not yet locked in.
The quarterly print looks strong on the surface: revenue up 23.5% YoY, profit up 34.3%, and Pricol outpaced the automotive market by a comfortable margin. Yet management maintained its guidance rather than raise it. The call reveals why: beneath the headline profit sits a margin story that explains everything.
₹1105.4 Cr
+23.5% YoY; outgrew market by 4%
+21.4% YoY
lagged revenue by 210 bps
₹67.0 Cr
+34.3% YoY (tax-benefited)
Maintained
not raised; FY31 target ₹8000 Cr
The margin compression story
Pricol's EBITDA margin fell to 11.4% from a normal 12.5–13%, a 140 basis point decline that absorbed most of the operating leverage from 23.5% revenue growth. The culprit: ₹150+ Crore in cost headwinds across raw materials (polymer, aluminum), LPG, freight rates, forex loss on imports, and state minimum wage hikes (~₹21 Crore annualised). The Polymer division bore the brunt, hitting 7.8% EBITDA margin—well below the company's 11% average.
With the prices being corrected, at least about 75% of our revenue, Q2 we will get some indexation and the balance will go to Q3…we are trying to improve this…another 0.5% EBITDA margin still in system via price & indexation if rupee stays stable.
Growth breakdown: where it came from
DICVS (Driver Information & Connected Vehicles) and ACFMS (Automotive Climate & Foam Molding) both grew ~25% YoY. The 2W segment outperformed its market, growing 28% vs 23% industry growth. New customer wins—Honda, Mahindra (entry into PV), and EV makers (Ather, Rivian, Simple Energy)—drove breadth across segments. Yet Polymer, despite capacity being the constraint, remains the growth challenge: ₹249 Cr revenue at 7.8% margin, with new plants (Hosur, Mysore, Aurangabad, Bhiwadi, Sanand) planned to double capacity from ₹1000 Cr to ₹2000 Cr over 18–24 months.
Revenue growth 23.5% YoY driven by industry strength + new products
Delivered +23.5% YoY; outgrew market (industry 22%, Pricol delivered 23.5%, representing 4% outgrowth narrative)
Supported
Margin loss temporary; recovery via Q2-Q3 price indexation (75%, then 25%)
~₹150+ Cr cost headwinds quantified; minimum wage (~₹21 Cr/yr) still under negotiation with OEMs; indexation not yet contractually locked
Partial—depends on execution
Polymer hit hardest by raw material and LPG inflation
Polymer revenue ₹249 Cr, EBITDA margin 7.8% vs ~11% company average
Supported
FY31 target of ₹8000 Cr revenue is credible
Grounded in ₹700 Cr CAPEX detailed (400 Cr Polymer, 150–180 Cr DICVS, 120 Cr ACFMS) and named customer wins (Honda, Mahindra, EV makers)
Supported—contingent on execution
What changed on this call
The CAPEX plan went from guidance of 680–700 Cr to a detailed ₹700 Cr roadmap over 18–24 months. The demerger of the DIS (Driver Information Systems) business was formally announced—management hopes for completion in 12 months, though regulatory timelines (SEBI/NCLT/ROC approvals) may extend this beyond the Vedanta precedent of 18–24 months. Customer wins became concrete: Honda (multi-year plastics contract), Mahindra (early PV engagement), and a portfolio of EV makers (Ather, Rivian, Simple Energy, Raptee, Royal Enfield). M&A was suspended for 12 months after due diligence revealed poor asset quality. New products (disc brakes, switches) were pushed to FY28 for material revenue, later than earlier hints suggested.
The bull-bear ledger
Revenue growth 23.5% YoY; outpaced market by 4%
Won major customers: Honda, Mahindra, EV makers; DIS market share 30–35% in 2W (largest in India)
Long-term target ₹8000 Cr by FY31 is quantified and grounded in ₹700 Cr CAPEX with named capacity additions
Demerger unlocks DIS agility for tech partnerships and capital-raising
EBITDA margin down 140 bps; recovery entirely dependent on unproven customer price indexation in Q2-Q3
Forex at all-time low; management flagged risk of rupee hitting 3-digit parity vs USD; no hedging detail disclosed
Polymer segment (7.8% EBITDA margin) capacity-constrained; new plants will take 9–12 months to ramp
Minimum wage negotiation (~₹21 Cr/yr) still open; customer acceptance not guaranteed
Customer concentration: Tata 8 of 10 PV cars; PV segment 8–9% market share (small but concentrated)
Risks ranked by severity
Indexation recovery non-realization
High₹150+ Cr margin recovery hinges on 75% of Q2 revenue and 25% of Q3 revenue getting price indexation. If customers resist (citing demand softness, competitive pressure), recovery is delayed or margin shortfall persists. Minimum wage negotiation (~₹21 Cr/yr) is still open.
Forex and commodity volatility
HighRupee at all-time lows; management flagged 3-digit (100+) parity risk. Iran war, shipping disruptions driving crude, LPG, freight high. Pricol's import exposure (electronic parts, aluminum) is material and unhedged per disclosure.
Capacity ramp execution
High5 new Polymer plants (Hosur, Mysore, Aurangabad, Bhiwadi, Sanand) to be commissioned over 18–24 months. Delays, cost overruns, or underutilization would cap Polymer margin recovery and growth, pushing FY31 target at risk.
Demerger legal and structural risk
Medium12-month target for demerger vs Vedanta's 18–24 months. Any regulatory delays would cloud strategy execution and capital allocation. Demerged entity must demonstrate standalone viability, adding execution complexity.
Customer concentration in PV
MediumTata 8 of 10 PV cars using Pricol DICVS. Loss of Tata business, a platform shift, or production cuts would be material. Diversification into EV and new OEMs is progressing but still early.
How the street is positioned
The stock closed at ₹792.05, just 37 paise below its all-time high of ₹795, up 55.6% from its 52-week low. RSI sits at 76.3, signalling overbought conditions. Post-result, the stock popped 2.29% on day 1 (36.6% of orders delivered), then gained further to +12.58% by day 3 and held at +11.81% by day 5, suggesting the market has broadly accepted the recovery narrative. Yet FII ownership fell from 15.61% (Q4 FY-2026) to 13.95% (Q1 FY-2027)—a net outflow of 1.66 percentage points despite strong growth and a bullish price move. This divergence (price up, FII selling) hints at institutional skepticism: the market has priced in the margin recovery already, leaving little room for disappointment. Volume trends remain normal, and there has been no insider selling near highs (bulk deals from June were at ₹628.47, well below current levels).
The debate
1 · Q2 FY-2027 EBITDA margin (Aug–Sep 2026 results, likely Oct 2026)
The litmus test. If indexation is real and customer negotiations succeed, EBITDA margin should recover toward 12–13%. Management guided 75% of Q2 revenue for indexation. If Q2 margin is flat or down from Q1 (11.4%), the recovery narrative breaks and downside risk emerges.
2 · Minimum wage negotiation outcome
~₹21 Cr annualised cost is still unresolved. Management is optimistic, but OEM agreement is not finalized. Clarity here either confirms or negates the 'delayed earnings' story. Watch for a detailed disclosure in Q2 results or call.
3 · Demerger regulatory progress (Oct 2026 onwards)
Operational separation from October, legal completion hoped for 12 months. Any delays or regulatory hurdles beyond that timeline could constrain capital-raising and tech partnerships for DIS. Track SEBI/NCLT filings and board updates.
4 · Polymer capacity ramp (announced for 9–12 months post-opening)
New plants coming in Hosur, Mysore, Aurangabad, Bhiwadi, Sanand. Delays or production ramp issues would signal execution risk and push margin recovery timeline beyond Q3.
Pricol is executing well on volume and winning new customers. But it's also a company where the next quarter determines whether margin compression is temporary or the start of a structural shift in profitability. The bull case hinges on two assumptions: (1) price indexation in Q2 will be accepted by major OEMs, and (2) external headwinds (forex, commodity, wage) won't worsen further. Both are reasonable, but neither is certain.
The stock has already priced in this recovery—it sits at ATH, RSI is overbought, and FII are reducing their stake. This is a 'hold pending confirmation' situation, not a 'buy on the dip' one. The single number to track from here is Q2 EBITDA margin. A recovery to 12%+ confirms the delayed-earnings narrative and validates the bull case. A flat or declining margin signals that cost headwinds may be stickier than expected, and the long-term profit trajectory is lower. That data point arrives in roughly six weeks.
Informational and educational content only. Not investment advice.